<?xml version="1.0" encoding="UTF-8"?>
<p>In the absence of an approved, safe and effective vaccine or a standard therapeutic option for mitigating the COVID-19 pandemic, scientists and public health experts have suggested the use of currently existing licensed vaccines/drugs, i.e., called repurposing of vaccines/drugs (used against other bacterial/viral infections) such as BCG vaccine,
 <sup>
  <xref rid="cit0019" ref-type="bibr">19</xref>
 </sup> antimicrobials, didanosine
 <sup>
  <xref rid="cit0020" ref-type="bibr">20</xref>
 </sup> and hydroxychloroquine,
 <sup>
  <xref rid="cit0021" ref-type="bibr">21</xref>,
  <xref rid="cit0022" ref-type="bibr">22</xref>
 </sup> antiparasitics, ivermectin
 <sup>
  <xref rid="cit0023" ref-type="bibr">23</xref>
 </sup> or combination of hydroxychloroquine and ivermectin,
 <sup>
  <xref rid="cit0024" ref-type="bibr">24</xref>
 </sup> antibiotics, azithromycin
 <sup>
  <xref rid="cit0025" ref-type="bibr">25</xref>
 </sup> or antiviral drugs ART
 <sup>
  <xref rid="cit0026" ref-type="bibr">26</xref>
 </sup> like lopinavir/ritonavir, favipiravir, and remdesivir
 <sup>
  <xref rid="cit0026" ref-type="bibr">26</xref>â€“
  <xref rid="cit0028" ref-type="bibr">28</xref>
 </sup> for the treatment of COVID-19.
 <sup>
  <xref rid="cit0029" ref-type="bibr">29</xref>
 </sup> Similarly, many advanced and novel therapeutics are also being tested for the treatment of COVID-19, including CAR T-cell,
 <sup>
  <xref rid="cit0030" ref-type="bibr">30</xref>
 </sup> stem-cell,
 <sup>
  <xref rid="cit0031" ref-type="bibr">31</xref>
 </sup> RNA Synthesis inhibitors,
 <sup>
  <xref rid="cit0032" ref-type="bibr">32</xref>
 </sup> Protease Inhibitors,
 <sup>
  <xref rid="cit0033" ref-type="bibr">33</xref>
 </sup> monoclonal antibodies,
 <sup>
  <xref rid="cit0034" ref-type="bibr">34</xref>,
  <xref rid="cit0035" ref-type="bibr">35</xref>
 </sup> and immunoglobulins-based therapy.
 <sup>
  <xref rid="cit0036" ref-type="bibr">36</xref>
 </sup>
</p>
